Ark Biosciences and KOLs Published a Review Paper on Antiviral Drug Resistance Across Chronic and Acute Infections

Antiviral therapy can lead to drug resistance, but multiple factors determine the frequency of drug resistance mutations and the clinical consequences. In this discussion paper, we consider the molecular factors contributing to antiviral drug resistance substitutions. The implications of resistance are considered for clinical trial endpoints and public health, as well as the requirements for therapeutic monitoring in clinical practice with acute viral infections.

For full article,

Wu 2018 AntivirRes acute vs chronic viral infection review_Page_01.jpg